InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 22
LONDON, UK / ACCESSWIRE / November 22, 2024 / The Company announces that on 21 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1) LONDON, UK / ACCESSWIRE / November 22, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), a biopharmaceutical company developing innovative therapies and treatments for blood diseases, is pleased to announce that the Institutional Review Board (IRB)of the Company's first clinical site has granted approval to initiate a Phase I clinical trial of the Company's lead asset, HEMO-CAR-T, which has now been given the formal designation HG-CT-1, for the treatment of relapsed/refractory (R/R) acute myeloid leukemia (AML) in adults. The proposed Phase 1 clinical trial is designed as a dose escalation study to assess the safety of HG-CT-1 in adult patients with R/R AML.
Ecora Resources PLC Announces Director Declaration
LONDON, UK / ACCESSWIRE / November 21, 2024 / Ecora Resources PLC (LSE:ECOR)(TSX:ECOR) announces that Graeme Dacomb, an independent Non-Executive Director of the Company, will be appointed as an independent Non-Executive Director of Capital Limited on 1 December 2024. Capital Limited is listed on the London Stock Exchange.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 21
LONDON, UNITED KINGDOM / ACCESSWIRE / November 21, 2024 / The Company announces that on 20 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares – November 20
LONDON, UNITED KINGDOM / ACCESSWIRE / November 20, 2024 / The Company announces that on 19 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Pantheon Resources PLC Announces Quarterly Repayment of Bonds and Private Placement
LONDON, UNITED KINGDOM / ACCESSWIRE / November 19, 2024 / Pantheon Resources plc (AIM:PANR)(OTCQX:PTHRF) ("Pantheon" or the "Company"), an oil and gas company developing the Kodiak and Ahpun oil fields in close proximity to pipeline and transportation infrastructure on Alaska's North Slope, announces that it has issued 9,108,756 new ordinary shares (the "New Ordinary Shares") in the Company via a private placement with the convertible bondholders (the "Private Placement") at an issue price of US$0.2878 (£0.2266) per ordinary share (the "Issue Price") for total proceeds of US$2.622 million. The Issue Price represents a 10 per cent.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
LONDON, UNITED KINGDOM / ACCESSWIRE / November 19, 2024 / The Company announces that on 18 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
InterContinental Hotels Group PLC (the Company) Purchase of own shares LONDON, UNITED KINGDOM / ACCESSWIRE / November 18, 2024 / The Company announces that on 15 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR
RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY CONFERENCE Parsortix-based HER2 kit being developed to provide an optimised, easily implemented, solution to enable product customers to undertake longitudinal, repeat assessment of HER2 status in breast cancer GUILDFORD, SURREY / ACCESSWIRE / November 15, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of new data at the American Association for Cancer Research (AACR) Special Conference in Cancer Research in San Diego, US from 13 to 16 November 2024. ANGLE is presenting a poster entitled the "Development of a scoring system to classify HER2 protein expression in Circulating Tumor Cells through immunofluorescence following isolation using Parsortix® instruments" and reports on progress of the Company's co-development programme with BioView.
Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may help to advance personalised treatment GUILDFORD, UNITED KINGDOM / ACCESSWIRE / November 15, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of new data at the American Association for Cancer Research (AACR) Special Conference in Cancer Research, Liquid Biopsy: From Discovery to Clinical Implementation, in San Diego, US from 13 to 16 November 2024. ANGLE is presenting a poster entitled "Investigating PD-L1 status in circulating tumor cells isolated from the blood samples of lung cancer patients".
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 15
Purchase of own shares LONDON, UK / ACCESSWIRE / November 15, 2024 / The Company announces that on 14 November 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Argo Blockchain PLC Announces Notice of Q3 Results
Notice of Q3 2024 Results and Investor Presentation LONDON, UK / ACCESSWIRE / November 14, 2024 / Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ:ARBK), announces that the Company's Q3 2024 results will be released on 20 November 2024. Argo will host a conference call to discuss its results at 10:00 ET / 15:00 GMT on 20 November 2024.
